Opus Genetics, Inc. (Nasdaq: IRD) (the "Company”, "Opus Genetics” or "Opus”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients ...
Upcoming Type B Statistical Methods Meeting expected to set stage for FDA to align with EMA and MHRA on use of Fall 2026 ...
The Federal Government launches phase two of the TVET programme, enhancing skills for young Nigerians, boosting employability ...
This secular, queer friendly addiction recovery group presents July opportunities. A weekly support group meets every Monday ...
The Securities and Exchange Commission (SEC) is proposing to make significant changes to the eligibility of issuers to utilize Securities ...
LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive ...
Oversubscribed $225 million concurrent private investment in public equity ("PIPE") with available cash to the combined ...
Detailed price information for Cartesian Therapeutics Inc (RNAC-Q) from The Globe and Mail including charting and trades.
Initiative is designed to accelerate development of new technologies for Belgian armed forces while also supporting country’s defense industry | Anadolu ...
According to a Bloomberg report, Bungie — the studio behind Destiny 2 and Marathon — is planning to make "a significant number of layoffs." This news comes shortly after the announcement it would be ...
Use left and right arrow keys to seek audio. Bungie is set to hold more job cuts following a decision to dial-back its breadwinning live service game. Disappointing news for Destiny fans today as ...
Stay informed on flood-related topics, including SB 3 implementation, by signing up for the TWDB “Flood” mailing list. For questions related to SB 3 implementation, please send an email to Flood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results